|
1
|
Chang JH, Gabison EE, Kato T and Azar DT:
Corneal neovascularization. Curr Opin Ophthalmol. 12:242–249. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Regenfuss B, Bock F, Parthasarathy A and
Cursiefen C: Corneal (lymph) angiogenesis - from bedside to bench
and back: a tribute to Judah Folkman. Lymphat Res Biol. 6:191–201.
2008. View Article : Google Scholar
|
|
3
|
Chevez-Barrios P: Are we getting closer to
prevention and treatment of corneal neovascularization? Clin
Experiment Ophthalmol. 35:689–690. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cursiefen C, Kuchle M and Naumann GO:
Angiogenesis in corneal diseases: histopathologic evaluation of 254
human corneal buttons with neovascularization. Cornea. 17:611–613.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gupta D and Illingworth C: Treatments for
corneal neovascularization: a Review. Cornea. 30:927–938. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lim P, Fuchsluger TA and Jurkunas UV:
Limbal stem cell deficiency and corneal neovascularization. Semin
Ophthalmol. 24:139–148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rundhaug JE: Matrix metalloproteinases and
angiogenesis. J Cell Mol Med. 9:267–285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ebrahem Q, Chaurasia SS, Vasanji A, et al:
Cross-talk between vascular endothelial growth factor and matrix
metalloproteinases in the induction of neovascularization in vivo.
Am J Pathol. 176:496–503. 2010. View Article : Google Scholar :
|
|
9
|
Hoeben A, Landuyt B, Highley MS, et al:
Vascular endothelial growth factor and angiogenesis. Pharmacol Rev.
56:549–580. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shibuya M: Differential roles of vascular
endothelial growth factor receptor-1 and receptor-2 in
angiogenesis. J Biochem Mol Biol. 39:469–478. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Olsson AK, Dimberg A, Kreuger J and
Claesson-Welsh L: VEGF receptor signalling - in control of vascular
function. Nat Rev Mol Cell Biol. 7:359–371. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stefanini MO, Wu FT, Mac Gabhann F and
Popel AS: The presence of VEGF receptors on the luminal surface of
endothelial cells affects VEGF distribution and VEGF signaling.
PLoS Comput Biol. 5:e10006222009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Turner CE: Paxillin. Int J Biochem Cell
Biol. 30:955–959. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brown MC and Turner CE: Paxillin: adapting
to change. Physiol Rev. 84:1315–1339. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abedi H and Zachary I: Vascular
endothelial growth factor stimulates tyrosine phosphorylation and
recruitment to new focal adhesions of focal adhesion kinase and
paxillin in endothelial cells. J Biol Chem. 272:15442–15451. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Birukova AA, Cokic I, Moldobaeva N and
Birukov KG: Paxillin is involved in the differential regulation of
endothelial barrier by HGF and VEGF. Am J Respir Cell Mol Biol.
40:99–107. 2009. View Article : Google Scholar :
|
|
17
|
Oh J, Diaz T, Wei B, et al: TIMP-2
upregulates RECK expression via dephosphorylation of paxillin
tyrosine residues 31 and 118. Oncogene. 25:4230–4234. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Petit V, Boyer B, Lentz D, et al:
Phosphorylation of tyrosine residues 31 and 118 on paxillin
regulates cell migration through an association with CRK in NBT-II
cells. J Cell Biol. 148:957–970. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rios A, Hernandez-Ramirez VI, Moguel M, et
al: Participation of Rho, ROCK-2, and GAP activities during actin
microfilament rearrangements in Entamoeba histolytica induced by
fibronectin signaling. Cell Biol Int. 32:984–1000. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsubouchi A, Sakakura J, Yagi R, et al:
Localized suppression of RhoA activity by Tyr31/118-phosphorylated
paxillin in cell adhesion and migration. J Cell Biol. 159:673–683.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dobkin-Bekman M, Naidich M, Rahamim L, et
al: A preformed signaling complex mediates GnRH-activated ERK
phosphorylation of paxillin and FAK at focal adhesions in L beta T2
gonadotrope cells. Mol Endocrinol. 23:1850–1864. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sachdev S, Bu Y and Gelman IH:
Paxillin-Y118 phosphorylation contributes to the control of
Src-induced anchorage-independent growth by FAK and adhesion. BMC
Cancer. 9:122009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jaffe EA, Nachamann RL, Becker CG and
Minick CR: Culture of human endothelial cells derived from
umbilical cord veins. Identification by morphologic and immunologic
criteria. J Clin Invest. 52:2745–2756. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Turner NA and Moake J: Assembly and
activation of alternative complement components on endothelial
cell-anchored ultra-large von Willebrand factor links complement
and hemostasis-thrombosis. Plos one. 8:e593722013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shan C, Xu F, Zhang S, et al: Hepatitis B
virus X protein promotes liver cell proliferation via a positive
cascade loop involving arachidonic acid metabolism and p-ERK1/2.
Cell Res. 20:563–575. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ng YS, Krilleke D and Shima DT: VEGF
function in vascular pathogenesis. Exp Cell Res. 312:527–537. 2006.
View Article : Google Scholar
|
|
28
|
Tammela T, Enholm B, Alitalo K and
Paavonen K: The biology of vascular endothelial growth factors.
Cardiovasc Res. 65:550–563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Van Geest RJ, Lesnik-Oberstein SY, Tan HS,
et al: A shift in the balance of vascular endothelial growth factor
and connective tissue growth factor by bevacizumab causes the
angiofibrotic switch in proliferative diabetic retinopathy. Br J
Ophthalmol. 96:587–590. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Velez-Montoya R, Clapp C, Rivera JC, et
al: Intraocular and systemic levels of vascular endothelial growth
factor in advanced cases of retinopathy of prematurity. Clin
Ophthalmol. 4:947–953. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ferrara N: Vascular endothelial growth
factor and age-related macular degeneration: from basic science to
therapy. Nat Med. 16:1107–1111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen JY, Tang YA, Huang SM, et al: A novel
sialyltransferase inhibitor suppresses FAK/paxillin signaling and
cancer angiogenesis and metastasis pathways. Cancer Res.
71:473–483. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang YN, Wang F, Zhou W, Wu ZQ and Xing
YQ: TNF-alpha stimulates MMP-2 and MMP-9 activities in human
corneal epithelial cells via the activation of FAK/ERK signaling.
Ophthalmic Res. 48:165–170. 2012. View Article : Google Scholar
|
|
34
|
Lee S, Zheng M, Kim B and Rouse BT: Role
of matrix metalloproteinase-9 in angiogenesis caused by ocular
infection with herpes simplex virus. J Clin Invest. 110:1105–1111.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bischoff J: Cell adhesion and
angiogenesis. J Clin Invest. 100:S37–S39. 1997.PubMed/NCBI
|
|
36
|
Hynes RO: Integrins: versatility,
modulation, and signaling in cell adhesion. Cell. 69:11–25. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wary KK, Kohler EE and Chatterjee I: Focal
adhesion kinase regulation of neovascularization. Microvasc Res.
83:64–70. 2012. View Article : Google Scholar
|
|
38
|
Teranishi S, Kimura K and Nishida T: Role
of formation of an ERK-FAK-paxillin complex in migration of human
corneal epithelial cells during wound closure in vitro. Invest
Ophthalmol Vis Sci. 50:5646–5652. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Takahashi T, Yamaguchi S, Chida K and
Shibuya M: A single autophosphorylation site on KDR/Flk-1 is
essential for VEGF-A-dependent activation of PLC-gamma and DNA
synthesis in vascular endothelial cells. EMBO J. 20:2768–2778.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Turner CE: Paxillin interactions. J Cell
Sci. 113:4139–4140. 2000.PubMed/NCBI
|
|
41
|
Hagel M, George EL, Kim A, et al: The
adaptor protein paxillin is essential for normal development in the
mouse and is a critical transducer of fibronectin signaling. Mol
Cell Biol. 22:901–915. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lai KM and Pawson T: The ShcA
phosphotyrosine docking protein sensitizes cardiovascular signaling
in the mouse embryo. Genes Dev. 14:1132–1145. 2000.PubMed/NCBI
|
|
43
|
Shaw LM, Rabinovitz I, Wang HH, Toker A
and Mercurio AM: Activation of phosphoinositide 3-OH kinase by the
alpha6beta4 integrin promotes carcinoma invasion. Cell. 91:949–960.
1997. View Article : Google Scholar
|
|
44
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
